Domenico Galetta

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Cancers

International journal of molecular sciences

Journal of clinical medicine

Journal of personalized medicine

IRCCS Ospedale Oncologico di Bari Giovanni Paolo II

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRCCS Ospedale Oncologico di Bari Giovanni Paolo II Nov 02 2016

Italy

M.D. Responsabile :: Oncologia Medica Patologia Toracica

Publications

Vito Longo, Annamaria Catino, Michele Montrone, Elisabetta Sara Montagna, Francesco Pesola, Ilaria Marech, Pamela Pizzutilo, Annalisa Nardone, Antonella Perrone, Monica Gesualdo, Domenico Galetta
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go. International journal of molecular sciences 25 (6) (2024)
Vito Longo, Annamaria Catino, Michele Montrone, Elisabetta Sara Montagna, Francesco Pesola, Ilaria Marech, Pamela Pizzutilo, Annalisa Nardone, Antonella Perrone, Monica Gesualdo, Domenico Galetta
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go. International journal of molecular sciences 25 (6) (2024)
Giulio Rossi, Luisella Righi, Francesca Barbisan, Marcello Tiseo, Paolo Spagnolo, Federica Grosso, Pasquale Pisapia, Umberto Malapelle, Marika Sculco, Irma Dianzani, Laura Abate-Daga, Maria Cristina Davolio, Giovanni Luca Ceresoli, Domenico Galetta, Giulia Pasello, Silvia Novello, Paolo Bironzo
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. Journal of personalized medicine 14 (4) (2024)
Vito Longo, Annamaria Catino, Michele Montrone, Elisabetta Sara Montagna, Francesco Pesola, Ilaria Marech, Pamela Pizzutilo, Annalisa Nardone, Antonella Perrone, Monica Gesualdo, Domenico Galetta
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will Go. International journal of molecular sciences 25 (6) (2024)
Giulio Rossi, Luisella Righi, Francesca Barbisan, Marcello Tiseo, Paolo Spagnolo, Federica Grosso, Pasquale Pisapia, Umberto Malapelle, Marika Sculco, Irma Dianzani, Laura Abate-Daga, Maria Cristina Davolio, Giovanni Luca Ceresoli, Domenico Galetta, Giulia Pasello, Silvia Novello, Paolo Bironzo
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. Journal of personalized medicine 14 (4) (2024)
Michele Montrone, Gerardo Rosati, Vito Longo, Annamaria Catino, Raffaella Massafra, Annalisa Nardone, Francesco Pesola, Elisabetta Sara Montagna, Ilaria Marech, Pamela Pizzutilo, Domenico Galetta
Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review. Journal of clinical medicine 12 (5) (2023)
Khalil Choucair, Caroline Nebhan, Alessio Cortellini, Stijn Hentzen, Yinghong Wang, Cynthia Liu, Raffaele Giusti, Marco Filetti, Paolo Antonio Ascierto, Vito Vanella, Domenico Galetta, Annamaria Catino, Nour Al-Bzour, Azhar Saeed, Ludimila Cavalcante, Pamela Pizzutilo, Carlo Genova, Melissa Bersanelli, Sebastiano Buti, Douglas B Johnson, Claudia Angela Maria Fulgenzi, David James Pinato, Maluki Radford, Chul Kim, Abdul Rafeh Naqash, Anwaar Saeed
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival. Cancers 15 (20) (2023)
Michele Montrone, Gerardo Rosati, Vito Longo, Annamaria Catino, Raffaella Massafra, Annalisa Nardone, Francesco Pesola, Elisabetta Sara Montagna, Ilaria Marech, Pamela Pizzutilo, Domenico Galetta
Immunotherapy in Elderly Patients Affected by Non-Small Cell Lung Cancer: A Narrative Review. Journal of clinical medicine 12 (5) (2023)
Antonio Rossi, Domenico Galetta
Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations. Cancers 14 (3) (2022)
Annamaria Catino, Rosanna Lacalamita, Simona De Summa, Francesco Pesola, Stefania Tommasi, Domenico Galetta
Multiple Genetic Alterations as Resistance Mechanism during Second-Line Lorlatinib for Advanced ALK-Rearranged Lung Adenocarcinoma: A Case Report. Diagnostics (Basel, Switzerland) 12 (3) (2022)
Raffaella Massafra, Annamaria Catino, Pia Maria Soccorsa Perrotti, Pamela Pizzutilo, Annarita Fanizzi, Michele Montrone, Domenico Galetta
Informative Power Evaluation of Clinical Parameters to Predict Initial Therapeutic Response in Patients with Advanced Pleural Mesothelioma: A Machine Learning Approach. Journal of clinical medicine 11 (6) (2022)
Antonio Passaro, Silvia Novello, Diana Giannarelli, Emilio Bria, Domenico Galetta, Alain Gelibter, Maria Lucia Reale, Simona Carnio, Emanuele Vita, Alessio Stefani, Pamela Pizzutilo, Valeria Stati, Ilaria Attili, Filippo de Marinis
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features. Cancers 13 (12) (2021)
Tiziana Vavalà, Annamaria Catino, Pamela Pizzutilo, Vito Longo, Domenico Galetta
Gender Differences and Immunotherapy Outcome in Advanced Lung Cancer. International journal of molecular sciences 22 (21) (2021)
Vito Longo, Annamaria Catino, Michele Montrone, Pamela Pizzutilo, Tiziana Annese, Francesco Pesola, Ilaria Marech, Sandro Cassiano, Domenico Ribatti, Domenico Galetta
What Are the Biomarkers for Immunotherapy in SCLC? International journal of molecular sciences 22 (20) (2021)
Alessia Di Gilio, Jolanda Palmisani, Gianrocco Ventrella, Laura Facchini, Annamaria Catino, Niccolò Varesano, Pamela Pizzutilo, Domenico Galetta, Massimo Borelli, Pierluigi Barbieri, Sabina Licen, Gianluigi de Gennaro
Breath Analysis: Comparison among Methodological Approaches for Breath Sampling. Molecules (Basel, Switzerland) 25 (24) (2020)
Vito Longo, Oronzo Brunetti, Amalia Azzariti, Domenico Galetta, Patrizia Nardulli, Francesco Leonetti, Nicola Silvestris
Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic Review. Cancers 11 (4) (2019)
Anna Maria Rachiglio, Francesca Fenizia, Maria Carmela Piccirillo, Domenico Galetta, Lucio Crinò, Bruno Vincenzi, Emiddio Barletta, Carmine Pinto, Francesco Ferraù, Matilde Lambiase, Agnese Montanino, Cristin Roma, Vienna Ludovini, Elisabetta Sara Montagna, Antonella De Luca, Gaetano Rocco, Gerardo Botti, Francesco Perrone, Alessandro Morabito, Nicola Normanno
The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients. Cancers 11 (3) (2019)

Domenico Galetta.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Domenico Galetta